Having shown that enhanced PDK1 expression plays an essential role in the PI3K/AKT/mTOR signaling axis and characterizes poorly differentiated aggressive HCC cells, to gain some insight into the mechanistic underlining of PDK1 on HCC oncogenicity and therapy response, we evaluated the effect of increasing doses of IR on different HCC cells. Here, AKT1 is linked to hepatocellular carcinoma.